Chemicals that fall under the umbrella of TRAPPC2L inhibitors are those that influence protein trafficking and cellular transport processes. Since TRAPPC2L is involved in the translocation of proteins from the endoplasmic reticulum to the Golgi apparatus, chemicals that disrupt this fundamental trafficking route may act as indirect inhibitors of TRAPPC2L's function. This indirect inhibition can be a result of disrupting vesicle formation, altering cytoskeletal dynamics, or interfering with molecular motors and proteins that facilitate the tethering and fusion of transport vesicles.
The chemical class named TRAPPC2L inhibitors would therefore encompass a variety of compounds that affect different aspects of cellular transport and trafficking. The inhibitors operate by impeding the function of proteins that interact with or regulate TRAPPC2L, or by altering the physical pathways along which TRAPPC2L operates. In essence, these chemicals disrupt the intracellular transportation infrastructure, creating a scenario where TRAPPC2L cannot perform its role effectively. This group of compounds, while diverse in their primary targets and mechanisms, share the common outcome of modulating the process in which TRAPPC2L is engaged, which is the critical factor defining their classification as TRAPPC2L inhibitors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER to Golgi protein trafficking by inhibiting ADP-ribosylation factor (ARF), which can indirectly influence TRAPPC2L's role in this process. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Ionophore that disrupts Golgi apparatus function by altering pH levels and can indirectly affect TRAPPC2L-related trafficking. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation in the ER, which can lead to a traffic jam effect, potentially impacting TRAPPC2L's function. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Specifically targets GBF1, a Golgi-specific brefeldin A-resistance factor 1, impeding trafficking between ER and Golgi, which could indirectly affect TRAPPC2L. | ||||||
Exo1 | 461681-88-9 | sc-200752 sc-200752A | 10 mg 50 mg | $84.00 $297.00 | 4 | |
Small molecule inhibitor that disrupts exocyst complex, potentially altering protein trafficking routes involving TRAPPC2L. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits NEDD8-activating enzyme essential for cullin-RING ligase function, which may indirectly affect protein trafficking and stability, impacting TRAPPC2L. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, similarly affecting cytoskeletal dynamics and indirectly the trafficking functions involving TRAPPC2L. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Inhibits actin polymerization, thereby possibly impacting vesicle movement and TRAPPC2L function. | ||||||